In summary, this study indicates that m6A regulator HNRNPC, as a predictor of prognosis and immunotherapy response based on bioinformatics analysis, is related to proliferation and invasion of NSCLC cells. This evidence concerns the gene METTL3 and non-small cell lung carcinoma.